Evaluation of OE-MRI in Patients With H&N Cancer

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 4, 2021

Primary Completion Date

November 28, 2022

Study Completion Date

February 1, 2023

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DIAGNOSTIC_TEST

Oxygen Enhanced MRI scan

Dynamic MRI scanning switching from breathing room air to high concentration oxygen part way through the scan.

Trial Locations (1)

Queens Medical Centre, Nottingham

All Listed Sponsors

lead

Nottingham University Hospitals NHS Trust

OTHER

NCT04724096 - Evaluation of OE-MRI in Patients With H&N Cancer | Biotech Hunter | Biotech Hunter